Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Research Focus in Biochemistry of Stem Cells Faculty of Medicine 1) Mesenchymal stem cells for regenerative medicine: Prof. Köller 2) Regenerative Medicine in Plastic Surgery: Prof. Steinsträsser 3) Ionophores as selective inhibitors of tumor stem cells and first approaches to clarify the underlying mechanisms: Dr. Bühler/Prof Adamietz 4) Epigenetics Changes in Tumor Cells: PD Dr. Mirmohammadsadegh Research Focus Prof. Dr. rer.nat. Manfred Köller Surgical Research University Hospital Bergmannsheil Bochum Surgical Research (Prof. Dr. Manfred Köller) Major research topics Harvest and cultivation of mesenchymal stem cells Differentiation of MSC Interaction of MSC with biomaterials Autologous plasma clot carrier matrices for bone fracture healing and neuroregeneration Interaction of MSC with nanoparticles Surgical Research, Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil, Bochum Mesenchymal stem cells for regenerative medicine Clinical success of stem cell research is related to clinically important answers How to make stem cells morph into the cell type needed (is that really needed ??) How to ensure the survival of stem cells ? How to home stem cells to sites of injury ? What is the optimal application method under clinical conditions ? MSC cultured on a porous calcium phosphate particle for fracture healing (calcein-AM / PI- stain) Mesenchymal stem cells for regenerative medicine Clinical Strategies Example: Osteogenic differentiation of MSC induced by supernatants of activated leukocytes (Alizarin red staining) Cell culture medium Non-Activated leukocyte medium Activated leukocyte medium Laboratory of Molecular Oncology and Wound Healing Department of Plastic Surgery, Burn Centre Prof. Dr. Lars Steinsträßer and Dr. Frank Jacobsen In vivo Models: - Rat - Mouse - Pig Human full skin model Proteomics and Pathophysiology Wound healing Host Defense Peptides Gene therapy approach Cell seeded scaffolds Artificial skin In vivo Models: - athymic mice - syngenic (BFS-1) mice In vitro and ex vivo tissue analysis Oncology of soft tissue sarcoma Oncolytic peptides as an alternative for sarcoma treatment Primary sarcoma Gene expression profiles, Mutation analysis, chromosome profiling Metastasis Ionophores as selective inhibitors of tumor stem cells and first approaches to clarify the underlying mechanisms. Na+K+ATPase activity might be the crucial factor. Dr. H. Bühler, Institut für Molekulare Onkologie, Strahlenbiologie und Experimentelle Strahlentherapie (IMOSES), Klinikum Marienhospital The stem cell hypothesis in cancer: „Tumors and recurrences originate from tumor stem cells“ We need specific therapeutic agents! a b <- E-cadherin CD24 negative <- vimentin CD44 positive breast cancer stem-like cells IMOSES <- keratin 18 a= wild type; b= epithelial) Test system for selective inhibitors: two subclones from a breast cancer cell line: • isolated stem cells • epithelial clone via the transfection of keratin 18 The viability of cancer stem cells is strongly reduced by salinomycin or narasin, whereas the epithelial clone is only marginally affected. MTS [OD] 140 viability [MTS] 120 120 100 100 80 80 60 E MDA231-St MDA231-K18 60 40 40 20 St 20 0 0 0 0 10-7 5*10-7 10-6 5*10-6 10-5 10-7 10-6 5*10-5 10-5 10-4 narasin [M] Salinomycin [M] both are ionophors for monovalent kations, e.g. Na+ und K+ intracellular K+ ist essential for the cell a Na+/K+-gradient has to be maintained against the interstitial fluid the main player is the enzyme Na+-K+-ATPase IMOSES Hypothesis: Tumor stem cells are more sensitive to salinomycin, due to a less active Na+-K+-ATPase compared to somatic cells. Adding hellebrin to the epithelial cells brings both graphs in line. But qRT-PCR of Na+K+ATPase expression revealed no significant difference between stem cells and the epithelial clone. MTS [OD] 140 E-cadherin 120 100 80 Na-K-ATPase 60 40 20 0 231K 231K+Hel 10-8 231K+Hel 2,5x10-8 231-St 0 5*10-7 epithelial 10-6 5*10-6 10-5 Salinomycin [M] However, a significantly lower concentration of ATP was observed in the stem cells. Hellebrin is a potent inhibitor of the Na+-K+-ATPase 1800 The Na+K+ATPase membrane transport is very energy consuming: 3 ATP are needed for every pair of kations. luminescence 1500 1200 900 600 300 IMOSES stem cells 0 MDA231-K MDA231-St Pathologie Bochum Epigenetics Changes in Tumor cells Alireza Mirmohammadsadegh Institut für Pathologie Ruhr-Universität Bochum www.pathologie-bochum.de Epigenetic gene-silencing events and tumorigenesis Study of heritable changes in gene expression or cellular phenotype caused by mechanisms other than changes in the underlying DNA sequence Epigenetic gene silencing & Epigenetic gene activation Advances in molecular techniques to study DNA methylation - Pyrosequencing (Quantitative positional methylation analysis) - Methylation CpG-3 CpG-2 CpG-1 Normal Cancer Molecular mechanisms of epigenetic gene silencing and activation during tumor progression Tumorigenesis Gene Silencing Courtesy: Baylin SB (2005) DNA methylation and gene silencing in cancer Nat Clin Pract Oncol 2